Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Open in API
Filings indexed 817 across all filing types
Latest filing 2021-10-27 Capital/Financing Update
Country IT Italy
Listing XMIL DIA

About Diasorin

https://diasoringroup.com/en

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
EMISSIONE DELLA “PHYSICAL SETTLEMENT NOTICE”
Capital/Financing Update Classification · 99% confidence The document is an official notice from DiaSorin S.p.A., identified by the header "Informazione Regolamentata n. 0957-62-2021" and the type "REGEM". The subject ("Oggetto") is "EMISSIONE DELLA 'PHYSICAL SETTLEMENT NOTICE'". The text explicitly states that the company has transmitted the 'Physical Settlement Notice' to bondholders of its equity-linked bonds, granting them the right to convert into ordinary shares starting November 19, 2021. This action relates to the conversion/exchange of debt instruments into equity, which falls under financing or capital structure changes. Given the specific nature of announcing the issuance of a notice related to the conversion terms of bonds, the most appropriate category is Capital/Financing Update (CAP). It is not a general regulatory filing (RNS) because it concerns a specific corporate finance event, nor is it a general earnings release (ER) or a full report (10-K/IR).
2021-10-27 Italian
By-laws (updated at October 4, 2021)
Regulatory Filings Classification · 98% confidence The document text consists of the full, detailed bylaws ('BYLAWS OF DIASORIN S.p.A.') updated on October 4th, 2021. It covers fundamental corporate structure elements like company name, registered office, purpose, term, share capital details (including a resolution on a bond conversion/share increase), shareholder meeting rules, and specific voting rights mechanisms (Increased voting right, Special List). This content is characteristic of a company's foundational governance document, which aligns best with Governance Information (CGR), which covers internal rules and board structure, or potentially a specific section within a larger filing like a 10-K or DEF 14A, but as a standalone document detailing internal rules, CGR is the most appropriate fit among the provided options. It is not an earnings release, audit report, or management discussion.
2021-10-21 English
Statuto sociale (aggiornato al 4 ottobre 2021)
Governance Information Classification · 98% confidence The document text is titled "STATUTO DI DIASORIN S.p.A." (Bylaws of Diasorin S.p.A.) and contains articles detailing the company's name, registered office, corporate purpose, duration, share capital, issuance of bonds, shareholder rights (including voting rights and the special voting share mechanism, 'maggiorazione del voto'), and rules for general meetings ('Assemblee'). This content is characteristic of a company's foundational governing document, which is typically filed as part of corporate governance disclosures. While it touches upon capital changes (Art. 5) and shareholder meetings (Art. 8, 9), the document itself is the Statute (Bylaws). Among the provided codes, 'Governance Information' (CGR) is the most appropriate fit for a document detailing the internal rules, structure, and governance practices, as explicitly mentioned in the definition for CGR: 'Report detailing the company's internal rules, board structure, and governance practices.' It is not a specific financial report (10-K, IR, ER) or a meeting announcement (AGM-R, DEF 14A).
2021-10-21 Italian
PUBLICATION OF THE SUMMARY REPORT OF THE VOTES CAST
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is a formal notification from DiaSorin, dated October 7, 2021, with the subject line 'PUBLICATION OF THE SUMMARY REPORT OF THE VOTES CAST'. The text explicitly states that the 'summary report of the votes cast at the extraordinary meeting of shareholders... was made available to the public today on the Company's corporate website'. This structure—a short announcement stating that a specific report (the vote summary) has been published online—fits the definition of a Report Publication Announcement (RPA). Although the content relates to voting results (DVA), the document itself is the *announcement* of the availability of that report, not the report itself, making RPA the most accurate classification based on the 'MENU VS MEAL' rule.
2021-10-07 English
PUBBLICAZIONE DEL RENDICONTO SINTETICO DELLE VOTAZIONI
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is a formal regulatory announcement (Informazione Regolamentata) from DiaSorin dated October 7, 2021. The subject ('Oggetto') is 'PUBBLICAZIONE DEL RENDICONTO SINTETICO DELLE VOTAZIONI' (Publication of the Summary Report of Voting Results). The text explicitly states that the summary report of the voting results related to the extraordinary shareholders' meeting held on October 4, 2021, has been made available to the public on the company website. Since this document is an announcement about the publication of voting results, and not the results themselves, it aligns best with the category for official results from shareholder votes (DVA) or, given the nature of the announcement itself, potentially a Report Publication Announcement (RPA). However, since the core subject matter is the voting results, DVA is the most specific fit for the content being announced. Given the short length and the explicit statement 'Vedasi allegato' (See attachment) and the announcement of publication, RPA is also a strong candidate based on Rule 2. Since the content is specifically about the voting results, DVA is chosen as the primary classification for the subject matter, but RPA captures the *action* of announcing the publication. Given the options, DVA (Declaration of Voting Results & Voting Rights Announcements) is the most precise classification for the *content* being released, even if this specific filing is the announcement of that release. If the document contained the actual results, it would definitively be DVA. Since it announces the availability of the results, and DVA covers the results themselves, I will check if DVA covers the announcement of results. DVA is defined as 'Official results from shareholder votes at any general meeting (AGM or EGM)'. Since this is the official announcement of those results, DVA is the most appropriate classification for the subject matter. Confidence is high due to the explicit subject line.
2021-10-07 Italian
THE EXTRAORDINARY SHAREHOLDERS’ MEETING OF DIASORIN AUTHORIZES THE CONVERTIBILITY OF THE EQUITY-LINKED BOND AND THE SHARE CAPITAL INCREASE
AGM Information Classification · 99% confidence The document is an official communication from DiaSorin dated October 4, 2021, regarding the authorization by the Extraordinary Shareholders' Meeting for the convertibility of an equity-linked bond and the resulting share capital increase. This action directly relates to the company's capital structure and financing activities. While it stems from a shareholder meeting, the core subject is the authorization of a capital increase tied to debt conversion, which aligns best with the 'Capital/Financing Update' definition (CAP). The text explicitly states the approval of the share capital increase for the sole purpose of serving the bond conversion. Although it mentions the meeting, the primary financial event being communicated is the capital change, not just the meeting results (DVA) or general AGM material (AGM-R). Given the focus on the financial transaction, CAP is the most appropriate classification.
2021-10-04 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.